Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
MASLD was associated with higher fibrosis stage in patients with CHB. Early detection and intervention are crucial to patients with three or more cardiometabolic risk factors.
Authors
- Fuyang Zhang (ORCID: https://orcid.org/0000-0002-6335-9809)
- Lingling He (ORCID: https://orcid.org/0000-0001-8082-8788)
- Hongshan Wei (ORCID: https://orcid.org/0000-0001-8893-653X)
- Junru Yang (ORCID: https://orcid.org/0000-0003-4030-7560)
- Ping Li (ORCID: https://orcid.org/0000-0003-1055-9505)
- Jing Zhang (ORCID: https://orcid.org/0000-0002-3082-8330)
- Hong Shan (ORCID: https://orcid.org/0000-0001-8222-4283)
- Lei Sun
- Yiwei Hao
Institutions
- Beijing YouAn Hospital (CN)
- Beijing Ditan Hospital (CN)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1016/j.aohep.2024.101589
- Citations
- 10
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.87